Oral vaccination against tetanus: Comparison of the immunogenicities of Salmonella strains expressing fragment C from the nirB and htrA promoters

Infection and Immunity

Volumn 66, Issue 7, 1998, Pages 3080-3087

  Roberts, Mark ^a   Li, Jingli ^b   Bacon, Andrew ^b   Chatfield, Steven ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; SALMONELLOSIS VACCINE; TETANUS TOXIN;

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL VIRULENCE; CLOSTRIDIUM TETANI; CONTROLLED STUDY; HELPER CELL; IMMUNOGENICITY; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SALMONELLA; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; STRAIN DIFFERENCE; SUBCUTANEOUS DRUG ADMINISTRATION; TETANUS;

EID: 0031814272     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.7.3080-3087.1998     Document Type: Article

References (46)

1. Anderson, R., G. Dougan, and M. Roberts. 1996. Delivery of the pertactin/ P.69 polypeptide of Bordetella pertussis using an attenuated Salmonella typhimurium vaccine strain: expression levels and immune response. Vaccine 14:1384-1390.
2. Bajaj, V., R. L. Lucas, C. Hwang, and C. A. Lee. 1996. Coordinate regulation of Salmonella typhimurium invasion genes by environmental and regulatory factors is mediated by control of hila expression. Mol. Microbiol. 22:703-714.
3. Baumler, A. J., J. G. Kusters, I. Stojiljkovic, and F. Heffron. 1994. Salmonella typhimurium loci involved in survival within macrophages. Infect. Immun. 62:1623-1630.
4. Brett, S. J., L. Dunlop, F. Y. Liew, and J. P. Tite. 1993. Influence of the antigen delivery system on immunoglobulin isotype selection and cytokine production in response to influenza a nucleoprotein. Immunology 80:306-312.
5. Cardenas, L., and J. D. Clements. 1992. Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens. Clin. Microbiol. Rev. 5:328-342.
6. Chabalgoity, J. A., C. M. A. Khan, A. A. Nash, and C. E. Hormaeche. 1996. A Salmonella typhimurium htrA live vaccine expressing multiple copies of a peptide comprising amino acids 8-23 of herpes simplex virus glycoprotein D as a genetic fusion to tetanus toxin fragment c protects mice from herpes simplex virus infection. Mol. Microbiol. 19:791-801.
7. Chacon, M. R., P. Londono, G. Dougan, and M. E. Selkirk. 1996. Heterologous expression of the cuticular glutathione-peroxidase of lymphatic filariae in an attenuated vaccine strain of Salmonella typhimurium abrogates H-2-restriction of specific antibody-responses. Parasite Immunol. 18:307-316.
8. Chatfield, S. N., I. G. Charles, A. J. Makoff, M. D. Oxer, G. Dougan, D. Pickard, D. Slater, and N. F. Fairweather. 1992. Use of the nirB promoter to direct the stable expression of heterologous antigens in salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine. Bio/Technology 10:888-892.
9. Chatfield, S. N., M. Roberts, G. Dougan, C. Hormaeche, and C. M. A. Khan. 1995. The development of oral vaccines against parasitic diseases utilizing live attenuated salmonella. Parasitology 110:S17-S24.
10. Chatfield, S. N., K. Strahan, D. Pickard, I. G. Charles, C. E. Hormaeche, and G. Dougan. 1992. Evaluation of Salmonella typhimurium strains harboring defined mutations in htrA and aroA in the murine salmonellosis model. Microb. Pathog. 12:145-151.
11. Clare, J. J., F. B. Rayment, S. P. Ballantine, K. Sreekrishna, and M. A. Romanos. 1991. High-level expression of tetanus toxin fragment C in Pichia postoris strains containing multiple tandem integrations of the gene. Bio/Technology 9:455-460.
12. Coulson, N. M., M. Fulop, and R. W. Titball. 1994. Effect of different plasmids on colonization of mouse tissues by the aromatic amino acid dependent Salmonella typhimurium SL3261. Microb. Pathog. 16:305-311.
13. Curtiss, R., III, J. E. Galan, K. Nakayama, and S. M. Kelly. 1990. Stabilization of recombinant avirulent vaccine strains in vivo. Res. Microbiol. 141:797-805.
14. Danese, P. N., and T. J. Silhavy. 1997. The sigma factor E and the Cpx signal transduction systems control the synthesis of periplasmic protein-folding enzymes in Escherichia coli. Genes Dev. 11:1183-1193.
15. Davis, R. W., D. Botstein, and J. R. Roth. 1980. Advanced bacterial genetics: a manual for genetic engineering. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
16. Everest, P., J. Allen, A. Papakonstantinopoulou, P. Mastroeni, M. Roberts, and G. Dougan. 1997. Salmonella typhimurium infections in mice deficient in interleukin-4 production - role of IL-4 in infection-associated pathology. J. Immunol. 159:1820-1827.
17. Everest, P., G. Frankel, J. Li, P. Lund, S. Chatfield, and G. Dougan. 1995. Expression of LacZ from the htrA, nirB and groE promoters in a salmonella vaccine strain: influence of growth in mammalian cells. FEMS Microbiol. Lett. 126:97-101.
18. Fairweather, N. F., V. A. Lyness, and D. J. Maskell. 1987. Immunization of mice against tetanus with fragments of tetanus toxin synthesized in Escherichia coli. Infect. Immun. 55:2541-2545.
19. Hoiseth, S. K., and B. A. D. Stocker. 1981. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291:238-239.
20. Johnson, K., I. Charles, G. Dougan, D. Pickard, P. Ogaora, G. Costa, T. Ali, I. Miller, and C. Hormaeche. 1991. The role of a stress-response protein in Salmonella typhimurium virulence. Mol. Microbiol. 5:401-407.
21. Karem, K. L., S. Chatfield, N. Kuklin, and B. T. Rouse. 1995. Differential induction of carrier antigen-specific immunity by Salmonella typhimurium live-vaccine strains after single mucosal or intravenous immunization of BALB/c mice. Infect. Immun. 63:4557-4563.
22. Khan, C. M. A., B. VillarrealRamos, R. J. Pierce, R. D. De Hormaeche, H. McNeill, T. Ali, S. Chatfield, A. Capron, G. Dougan, and C. E. Hormaeche. 1994. Construction, expression, and immunogenicity of multiple tandem copies of the Schistosoma mansoni peptide 115-131 of the P28 glutathione S-transferase expressed as C-terminal fusions to tetanus toxin fragment C in a live aro-attenuated vaccine strain of salmonella. J. Immunol. 153:5634-5642.
23. Lee, C. A., and S. Falkow. 1990. The ability of salmonella to enter mammalian cells is affected by bacterial growth state. Proc. Natl. Acad. Sci. USA 87:4304-4308.
24. Lipinska, B., O. Fayet, L. Baird, and C. Georgopoulos. 1989. Identification, characterization, and mapping of the Escherichia coli htrA gene, whose product is essential for bacterial growth only at elevated temperatures. J. Bacteriol. 171:1574-1584.
25. Lipinska, B., S. Sharma, and C. Georgopoulos. 1988. Sequence-analysis and regulation of the htrA gene of Escherichia coli - a sigma-32-independent mechanism of heat-inducible transcription. Nucleic Acids Res. 16:10053-10067.
26. Lipinska, B., M. Zylicz, and C. Georgopoulos. 1990. The HtrA (DegP) protein, essential for Escherichia coli survival at high temperatures, is an endopeptidase. J. Bacteriol. 172:1791-1797.
27. Londono, L. P., S. Chatfield, R. W. Tindle, K. Herd, X. M. Gao, I. Frazer, and G. Dougan. 1996. Immunization of mice using Salmonella typhimurium expressing human papillomavirus type-16 E7 epitopes inserted into hepatitis-b virus core antigen. Vaccine 14:545-552.
28. Maskell, D. J., K. J. Sweeney, D. Ocallaghan, C. E. Hormaeche, F. Y. Liew, and G. Dougan. 1987. Salmonella typhimurium aroA mutants as carriers of the Escherichia coli heat-labile enterotoxin-b subunit to the murine secretory and systemic immune systems. Microb. Pathog. 2:211-221.
29. Mecsas, J., P. E. Rouviere, J. W. Erickson, T. J. Donohue, and C. A. Gross. 1993. The activity of sigma factor E, an Escherichia coli heat-inducible sigma factor, is modulated by expression of outer-membrane proteins. Genes Dev. 7:2618-2628.
30. Missiakas, D., and S. Raina. 1997. Protein misfolding in the cell envelope of Escherichia coli: new signaling pathways. Trends Biochem. Sci. 22:59-63.
31. Nakayama, K., S. M. Kelly, and R. Curtiss III. 1988. Construction of an asd+ expression-cloning vector: stable maintenance and high level expression of cloned genes in a salmonella vaccine strain. Bio/Technology 6:693-697.
32. Oxer, M. D., C. M. Bentley, J. G. Doyle, T. C. Peakman, I. G. Charles, and A. J. Makoff. 1991. High-level heterologous expression in Escherichia coli using the anaerobically-activated nirB promoter. Nucleic Acids Res. 19: 2889-2892.
33. Pogliano, J., A. S. Lynch, D. Belin, E. C. C. Lin, and J. Beckwith. 1997. Regulation of Escherichia coli cell envelope proteins involved in protein folding and degradation by the Cpx two-component system. Genes Dev. 11:1169-1182.
34. Roberts, M., A. Bacon, R. Rappuoli, M. Pizza, I. Cropley, G. Douce, G. Dougan, M. Marinaro, J. McGhee, and S. Chatfield. 1995. A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/ 129G, is an effective mucosal adjuvant for intranasally delivered proteins. Infect. Immun. 63:2100-2108.
35. Roberts, M., S. N. Chatfield, and G. Dougan. 1994. Salmonella as carriers of heterologous antigens, p. 27-58. In D. T. O'Hagan (ed.), Novel delivery systems for oral vaccines. CRC Press, Boca Raton, Fla.
36. Rouviere, P. E., A. D. L. Penas, J. Mecsas, C. Z. Lu, K. E. Rudd, and C. A. Gross. 1995. rpoE, the gene encoding the 2nd heat-shock sigma-factor, sigma factor E, in Escherichia coli. EMBO J. 14:1032-1042.
37. E) which controls mucoidy in cystic fibrosis isolates of Pseudomonas aeruginosa. J. Bacteriol. 177:5670-5679.
38. Seol, J. H., S. K. Woo, E. M. Jung, S. J. Yoo, C. S. Lee, K. J. Kim, K. Tanaka, A. Ichihara, D. B. Ha, and C. H. Chung. 1991. Protease Do is essential for survival of Escherichia coli at high temperatures - its identity with the htrA gene-product. Biochem. Biophys. Res. Commun. 176:730-736.
39. Snyder, W. B., L. J. B. Davis, P. N. Danese, C. L. Cosma, and T. J. Silhavy. 1995. Overproduction of NlpE, a new outer membrane lipoprotein, suppresses the toxicity of periplasmic LacZ by activation of the Cpx signal transduction pathway. J. Bacteriol. 177:4216-4223.
40. Stanfield, J. P., and A. Galazka. 1984. Neonatal tetanus in the world today. Bull. W. H. O. 62:647-669.
41. Strauch, K. L., K. Johnson, and J. Beckwith. 1989. Characterization of degP, a gene required for proteolysis in the cell envelope and essential for growth of Escherichia coli at high temperature. J. Bacteriol. 171:2689-2696.
42. Strugnell, R., G. Dougan, S. Chatfield, I. Charles, N. Fairweather, J. Tite, L. Jing Li, J. Beesley, and M. Roberts. 1992. Characterization of a Salmonella typhimurium aro vaccine strain expressing the P.69 antigen of Bordetella pertussis. Infect. Immun. 60:3994-4002.
43. Strugnell, R. A., D. Maskell, N. Fairweather, D. Pickard, A. Cockayne, C. Penn, and G. Dougan. 1990. Stable expression of foreign antigens from the chromosome of Salmonella typhimurium vaccine strains. Gene 88:57-63.
44. Tacket, C. O., D. M. Hone, G. A. Losonsky, L. Guers, R. Edelman, and M. M. Levine. 1992. Clinical acceptability and immunogenicity of CVD908 Salmonella typhi vaccine strain. Vaccine 10:443-446.
45. Vancott, J. L., H. F. Staats, D. W. Pascual, M. Roberts, S. N. Chatfield, M. Yamamoto, M. Coste, P. B. Carter, H. Kiyono, and J. R. McGhee. 1996. Regulation of mucosal and systemic antibody-responses by T-helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant salmonella. J. Immunol. 156:1504-1514.
46. Yang, D. M., N. Fairweather, L. L. Button, W. R. McMaster, L. P. Kahl, and F. Y. Liew. 1990. Oral Salmonella typhimurium (aroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis. J. Immunol. 145:2281-2285.